Dolutegravir/abacavir/lamivudine FDC
117172
Phase 3 small_molecule completed
Quick answer
Dolutegravir/abacavir/lamivudine FDC for Infection, Human Immunodeficiency Virus is a Phase 3 program (small_molecule) at ViiV Healthcare B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ViiV Healthcare B.V.
- Indication
- Infection, Human Immunodeficiency Virus
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed